Association between serum adipsin and plaque vulnerability determined by optical coherence tomography in patients with coronary artery disease.
Association between serum adipsin and plaque vulnerability determined by optical coherence tomography in patients with coronary artery disease.
复制标题
DOI:
10.21037/jtd-21-259
复制
发表时间:
2021-04
影响因子:
2.5
通讯作者:
Tang C
中科院分区:
文献类型:
--
作者:
Sun R;Qiao Y;Yan G;Wang D;Zuo W;Ji Z;Zhang X;Yao Y;Ma G;Tang C
Early identification of vulnerable plaques is important for patients with coronary artery disease (CAD) to reduce acute coronary events and improve their prognosis. We sought to examine the relationship between adipsin, an adipokine secreted from adipocytes, and plaque vulnerability in CAD patients. A total of 103 plaques from 99 consecutive patients who underwent coronary angiography were assessed by optical coherence tomography. The serum level of adipsin was measured using enzyme-linked immunosorbent assay (ELISA). The accuracy of adipsin for detecting thin-cap fibroatheroma (TCFA) was determined by the area under the receiver operating characteristic curve (AUC). Of the 99 patients, 49 were classified into the low adipsin group and 50 into the high adipsin group according to the median level of serum adipsin (2.43 µg/mL). The plaques from the high adipsin group exhibited a greater lipid index (2,700.0 vs. 1,975.9° × mm, P=0.015) and an increased proportion of TCFAs (41.2% vs. 21.2%, P=0.028) compared with the low adipsin group. Serum adipsin was found to be negatively correlated with fibrous cap thickness (ρ=−0.322, P=0.002), while it was positively correlated with average lipid arc (ρ=0.253, P=0.015), maximum lipid arc (ρ=0.211, P=0.044), lipid core length (ρ=0.241, P=0.021), lipid index (ρ=0.335, P=0.001), and vulnerability score (ρ=0.254, P=0.014). Furthermore, adipsin had a significant association with TCFAs (OR: 1.290, 95% CI: 1.048–1.589, P=0.016) in the multivariate analysis, while having a moderate diagnostic accuracy for TCFAs (AUC: 0.710, 95% CI: 0.602–0.817, P<0.001). Our findings suggest that serum adipsin is significantly and positively correlated with the incidence of TCFAs. The application of adipsin as a biomarker may offer improvement in the diagnosis of vulnerable plaques and clinical benefits for CAD patients.
登录
查看更多内容
影响因子:
6.7
作者:
Hertle, Elisabeth;Arts, Ilja C. W.;van Greevenbroek, Marleen M. J.
通讯作者:
van Greevenbroek, Marleen M. J.
影响因子:
9.3
作者:
Leinhase, Iris;Rozanski, Michal;Harhausen, Denise;Thurman, Joshua M.;Schmidt, Oliver I.;Hossini, Amir M.;Taha, Mohy E.;Rittirsch, Daniel;Ward, Peter A.;Holers, V. Michael;Ertel, Wolfgang;Stahel, Philip F.
通讯作者:
Stahel, Philip F.
影响因子:
24
作者:
Jia, Haibo;Abtahian, Farhad;Aguirre, Aaron D.;Lee, Stephen;Chia, Stanley;Lowe, Harry;Kato, Koji;Yonetsu, Taishi;Vergallo, Rocco;Hu, Sining;Tian, Jinwei;Lee, Hang;Park, Seung-Jung;Jang, Yang-Soo;Raffel, Owen C.;Mizuno, Kyoichi;Uemura, Shiro;Itoh, Tomonori;Kakuta, Tsunekazu;Choi, So-Yeon;Dauerman, Harold L.;Prasad, Abhiram;Toma, Catalin;McNulty, Iris;Zhang, Shaosong;Yu, Bo;Fuster, Valentine;Narula, Jagat;Virmani, Renu;Jang, Ik-Kyung
通讯作者:
Jang, Ik-Kyung
DOI:
10.1161/atvbaha.108.179705
发表时间:
2012-09
期刊:
Arteriosclerosis, thrombosis, and vascular biology
影响因子:
--
作者:
Libby P
通讯作者:
Libby P
影响因子:
64.5
作者:
Lo JC;Ljubicic S;Leibiger B;Kern M;Leibiger IB;Moede T;Kelly ME;Chatterjee Bhowmick D;Murano I;Cohen P;Banks AS;Khandekar MJ;Dietrich A;Flier JS;Cinti S;Blüher M;Danial NN;Berggren PO;Spiegelman BM
通讯作者:
Spiegelman BM